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Introduction
Calcium channel blockers (CCB) are a leading cause of 
mortality from drug overdose among cardiovascular medicine [1]. 
CCBs are commonly used for treating hypertension, angina, and 
arrhythmias. However in an overdose, this can lead to cardiogenic 
shock that is difficult to treat with vasopressors alone and is 
especially problematic for long-acting agents such as amlodipine. 
Insulin is widely used in treatment of diabetes mellitus, 
hypertriglyceridemia, and hyperkalemia. High dose insulin 
(HDI) therapy, defined as >0.5 units/kg/hr, has been postulated 
to improve hemodynamics in CCB poisonings given its positive 
inotropic and vasodilatory effects at the capillary beds leading to 
decreased vascular resistance and improved cardiac output.
Case Presentation
A 52 year old female with a history of hypertension, depression 
and previous suicide attempts was brought into the emergency 
department (ED) with acute encephalopathy. EMS found the 
patient on her bed with snoring respirations and was very difficult 
to arouse. There was a suicide note by the patient stating that she 
took amlodipine. There were no family members or housemates 
nearby, so the onset of ingestion could not be determined.
Upon arrival in the ED, the patient was found to be hypotensive 
with blood pressure 68/53. The patient weighed 65.6 kg. On 
exam, she appeared stuporous. There were significant snoring 
respirations but no other abnormal lung sounds were appreciated 
bilaterally. Heart auscultation was unremarkable. There were no 
signs of acute injury on abdominal exam. Cranial nerves 2-12 
were grossly intact. She opens her eyes to her name and has 
spontaneous movements in all extremities but she does not 
follow commands. Initial laboratory studies, as shown in Table 1, 
revealed hypokalemia and mildly decreased CO2. The corrected 
calcium was normal, measured at 8.9. Urinalysis was not 
suggestive of a UTI and otherwise unremarkable. Her chest x-ray 
and computed tomography of the head on admission revealed no 
acute pathology. 
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Case Report
Endocrinol Metab Int J 2017, 5(3): 00123
Abstract
Introduction: High dose insulin (HDI) therapy, defined as > 0.5 units/kg/hour, 
has been postulated to improve hemodynamics in both calcium channel blocker 
(CCB) and beta-blocker overdose. Proposed benefits of HDI include coronary 
and systemic vasodilation due to enhancement of nitric oxide synthase activity 
leading to improved contractility and decreased systemic vascular resistance, 
respectively. HDI also directly improves cardiac contractility by increasing 
glucose uptake and improving calcium handling within cardiac cells. We present 
a case of a patient with amlodipine overdose and her response to HDI therapy.
Case presentation: A 52 year old female presented with amlodipine overdose 
after suicide attempt leading to shock. She received continuous intravenous 
infusion of regular insulin at a rate of 2 units/kg/hour and epinephrine titrated 
up to 80 mcg/hour to maintain mean arterial pressure above 65. After several 
hours, there was concern for worsening hypokalemia so insulin was suspended. 
Patient subsequently became more hypotensive, requiring further uptitration of 
epinephrine. When continuous insulin was later restarted, there was an observed 
immediate improvement in blood pressure. Patient was eventually weaned off of 
vasopressors, followed by insulin, by day 3. She was downgraded from the ICU 
on day 5.
Conclusion: In patients with CCB overdose, initial management should include 
fluid resuscitation, calcium supplementation, and early consideration of 
vasopressors and HDI therapy. Although there are currently no controlled human 
studies to evaluate the benefits of HDI therapy, this case revealed worsening 
hypotension upon cessation of therapy followed by rapid improvement in blood 
pressure when restarting insulin. Based on this observation, HDI therapy may 
have a prominent role in management of CCB overdose.
Keywords: Amlodipine; High dose insulin; Hypertension; Arrhythmias; Insulin; 
Cardiogenic shock
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Table 1: Laboratory studies during hospital course.
Time Day 1 Day 2 Day 3 Day 4
Sodium 138 136 133 134
Potassium 3.0 2.9 4.3 3.5
Chloride 108 109 107 104
CO2 19 12 19 26
Anion Gap 11 15 7 4
Glucose 139 390 113 72
BUN 22 26 18 9
Creatinine 1.02 1.81 0.73 0.503
Calcium 8.3 7.5 7.0 6.8







Lactic Acid 1.5 7.4 4.1 1.8
Creatine Kinase 86
Troponin-I <0.015
Patient was given 3 liter boluses of normal saline and 4 gm 
of calcium gluconate without adequate response to the blood 
pressure. She was started on intravenous regular insulin at a rate 
of 150 units per hour with dextrose 10% in water at rate of 50 ml/
hr. Epinephrine was administrated at the same time and titrated 
up to 80 mcg per minute to maintain mean arterial pressure above 
65. Potassium chloride supplements were also administered to 
prevent hypokalemia while on insulin infusion. 
Approximately eight hours after admission (day 2), the next 
renal panel revealed a potassium level of 2.9. Given concern for 
continued worsening of hypokalemia, the insulin infusion was 
suspended. Two hours later, mean arterial pressure dropped 
significantly requiring uptitration of epinephrine up to 90 mcg/
minute. Patient was subsequently noted to be more somnolent, 
and she was intubated for airway protection. 3 hours after 
suspending insulin, it was then restarted at 150 units per hour 
with dextrose 10% at 50 ml/hr. Almost immediately afterwards, 
there was an observed improvement in mean arterial pressure.
Over the next 24 hours, potassium was supplemented 
approximately 40-50 mEq every 4 hours along with magnesium 
and phosphorus. Potassium levels were well maintained and 
never went below 3.2. The most notable adverse effect was 
hypoglycemia but responding well to dextrose 50% pushes and 
increased dextrose 10% continuous infusion rate up to 140 ml 
per hour. The patient continued to show improvement in blood 
pressure. By day 4, insulin and epinephrine were weaned off 
completely and the patient was downgraded from the ICU on day 
5.
Discussion
Two main classes of CCBs exist on the market: dihydropyridines 
and non-dihydropyridines (Table 2). Non-dihydropyridine CCBs 
have a strong affinity for the myocardium, including cardiac 
myocytes and pacemaker cells. They decrease myocardial 
contractility, decreased heart rate, and decreased conductivity 
making them useful for treating angina or cardiac arrhythmias. 
Amlodipine is a type of long-acting dihydropyridine CCB. At 
therapeutic doses, this class of CCBs act predominantly on L-type 
calcium channels on vascular smooth muscle cells with little effect 
on the myocardium [2]. Amlodipine is commonly prescribed for 
hypertension given its favorable adverse effect profile compared 
to other antihypertensive agents. In severe dihydropyridine CCB 
overdose, there is less selectivity for peripheral vascular effects 
and cardiac adverse effects may be seen leading to refractory 
cardiogenic shock. CCB overdose may also inhibit L-type channels 
of pancreatic islet cells which decreases insulin release and can 
cause hyperglycemia [3]. Other non-cardiovascular adverse 
effects following CCB overdose include confusion, agitation, 
altered mentation, and seizures likely due to decreased cerebral 
perfusion from hypotension [4]. 
Table 2: Common CCBs used in the US.









Numerous animal studies have shown beneficial effects of 
HDI therapy. In canines, HDI therapy was compared to other 
conventional therapies and showed significant improvement in 
myocardial contractility [5]. Canines induced with propranolol 
with subsequent myocardial depression and later treated with 
HDI showed reversal of myocardial depression [6]. In swine 
models, HDI and epinephrine therapy exhibited similar increases 
in myocardial contractility but epinephrine effects appeared to be 
temporary, lasting up to 90 minutes despite continuous infusion 
up to a maximum dose of 50 mcg/kg/min. In contrast, HDI therapy 
maintained myocardial contractility significantly longer leading to 
marked increase in survival among the HDI group [7]. Nifedipine 
overdose in pigs treated with HDI versus combination HDI and 
vasopressors show no significance in survivability, cardiac index, 
and mean arterial pressure [8].
Many mechanisms have been proposed for the positive 
effects of HDI therapy. In contrast to vasopressors, HDI acts as 
a vasodilator in systemic, coronary, and pulmonary vasculature 
due to enhancement of endothelial nitric oxide synthase activity. 
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Insulin enhances microvascular perfusion by increasing total 
blood flow to the capillary beds in the setting of cardiogenic shock. 
This effect decreases vascular resistance and enhances cardiac 
output [9]. During states of significant stress, the myocardium 
primarily uses glucose as the preferred energy substances in 
contrast to fatty acids under non-stressed states. Insulin increases 
intracellular transport of glucose in cardiac muscle, and this is 
believed to contribute to increased myocardial contractility [10]. 
This effect has also been studied in explanted human myocardium 
and show increased inotropic function when exposed to insulin 
[11] (Image 1).
Many case reports have implicated beneficial effects of HDI 
therapy in calcium channel blocker and beta-blocker poisoning. 
There is no recommended standard dosing and rate of insulin 
administration but most clinicians administer an initial insulin 
bolus 1 unit/kg followed by a 0.5-2 units/kg/hour continuous 
infusion. Benefits have been reported in as little as 0.015 units/
kg/hour up to 22 units/kg/hour. HDI therapy is typically started 
early during cardiogenic shock and at the same time as starting 
vasopressors [9,12,13]. Once the patient is hemodynamically 
stable, vasopressors are weaned off first followed by HDI therapy. 
Cases in the literature report worse outcome and decreased 
survival when HDI therapy is not started early likely because of 
the temporarily benefits from vasopressor alone and the lack of 
positive inotropic effects of insulin [9].
The most common adverse effect of HDI therapy is 
hypoglycemia. Administration of 5-10% dextrose continuous 
infusion and high dose dextrose pushes is given concomitantly 
with HDI therapy to maintain euglycemia. Consideration of glucose 
infusions greater than 10% through a central venous catheter 
may be warranted if there is concern for fluid overload. Frequent 
glucose checks initially every 10 minutes is recommended until 
glucose levels stabilize. Dextrose supplementation may need 
to be continued post HDI therapy due to persistent insulin 
concentrations. Hypokalemia is another concern of HDI therapy, 
as is the case with insulin infusions during treatment of diabetic 
ketoacidosis or hyperglycemic hyperosmolar nonketotic state. 
Fortunately, severe hypokalemia as defined by the presence of 
EKG changes is rarely seen with HDI therapy when supplemented 
with continuous or bolus potassium replacements. This is likely 
due to the shifting of potassium cations into the cell and not 
total body depletion of potassium. Potassium, magnesium, and 
phosphorus levels also should be checked frequently until levels 
have stabilized. 
Currently, there are no clinical trials to compare the efficacy 
of HDI therapy alone versus vasopressor therapy alone or 
vasopressor and HDI therapy. Levine et al. evaluated 45 patients 
overdosed on CCBs and showed good survival outcome on 
vasopressor therapy alone [14]. However, early initiation of HDI 
has been implicated in many controlled animal trials and clinical 
case reports as beneficial therapy for CCB overdose. We presented 
a case of a patient who overdosed on amlodipine. Due to concerns 
for worsening hypokalemia, insulin therapy was held and 
subsequently there was an observed worsening of hemodynamic 
status. Upon re-initiation of insulin there was an immediate 
improvement in mean arterial blood pressures suggesting that 
HDI therapy may play a significant role in CCB overdose.
Initial CCB overdose management should include IV fluid 
resuscitation, consideration of intubation for airway protection 
if necessary, and laboratory/imaging studies to rule out other 
contributory diagnoses including infection and polysubstance 
use. Gastric lavage or activated charcoal may be considered if 
patients present less than 1 hour post-ingestion. IV calcium is 
also recommended in early management for improvement in 
contractility and blood pressure because it is readily available 
and carries little risk [15-18]. Vasopressor and HDI therapy 
should be considered early to maintain mean arterial pressures 
with frequent glucose and electrolyte monitoring. While our 
patient experienced hypoglycemia and hypokalemia, both issues 
were well managed with continuous dextrose infusions and 
conventional potassium replacement protocols. Based on this 
case and other case studies in the literature, HDI appears to be a 
promising treatment for CCB poisoning.
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